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Aging is now viewed as a plastic phenotype that can be 
altered by nutritional, pharmacological and genetic 
manipulations. However, most pro-longevity mutations 
are discovered by systematic gene deletion or RNA 
interference screens, which mainly reveal abolished or 
diminished gene functions [1]. In our recent 
publications [2, 3], we used global acetylation proteome 
screens to study aging in yeast, and showed that 
enhancing the function of certain genes through specific 
acetylation can promote longevity. The genes involved 
are by no means strangers – acetylation of yeast AMPK 
regulatory subunit by the essential lysine acetyl-
transferase (KAT) complex NuA4 leads to increased 
protein-protein interaction and extension of lifespan. 
 
It is well known that acetylation of histone proteins in 
cultured human fibroblasts decreases during aging, 
which is believed to be directly related to decreased 
metabolic rate and reproductive capacity associated 
with aging [4]. However, histone deacetylation is not 
likely to be a universal driving force of aging because 
histone acetylation and deacetylation mimetics similarly 
shortened life span [5], which could simply reflect 
nonspecific fitness decreases in both instances. 
Extension of lifespan promoted by certain genetic 
and/or pharmacological perturbations will more likely 
lead to identification of bona fide regulatory factors of 
aging. 
 
Starting from a proteome-wide search for non-histone 
substrates of NuA4 complex, we unexpectedly found 
Sip2, one of the three regulatory β subunit of yeast 
AMPK, could be acetylated and  deacetylated  by NuA4  
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and Rpd3, respectively. Sip2 acetylation enhances its 
interaction with the yeast AMPK catalytic subunit, 
Snf1, and inhibits its kinase activity. Interestingly, Sip2 
acetylation declined significantly with yeast replicative 
aging. Restoration of Sip2 acetylation by deleting the 
deacetylase Rpd3 or through use of acetylation 
mimetics both slowed cellular growth, increased 
resistance to oxidative damage, and increased lifespan. 
These pro-longevity effects result from reduced AMPK 
catalytic activity and subsequent activation of 
downstream target Sch9 [2].  
 
We note that a similar mixed acetyltransferase kinase 
cascade exists in mammalian cells, with the NuA4 
homolog Tip60 acetyltransferase complex at the "top", 
possibly counteracted by a deacetylase, in which the 
acetylation signal is transmitted to a cascade of two 
kinases, ATM/ATR - CHK1/CHK2,to execute a crucial 
DNA damage response [6]. Thus this may represent a 
common motif in eukaryotic regulatory networks that 
was not previously appreciated (Figure 1). 
 
Aging is conventionally thought to be characterized by 
accumulation of molecular, cellular, and organ damage, 
leading to increased vulnerability to disease and 
death[7]. Our data, on the contrary, support the idea that 
the gradual loss of a crucial component promoting 
“healthy young status” might underlie an intrinsic aging 
process. Many of the mutations that extend life span 
decrease the activity of external nutrient signaling, such 
as the IGF (insulin-like growth factor)/insulin and the 
TOR (target of rapamycin) pathways, suggesting that 
they may induce a metabolic state similar to that 
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dietary restriction can also have destructive effects, 
impairing critical functions such as immunity, causing 
susceptibility to infections [7]. Our results suggest the 
possible benefit of manipulating an intrinsic aging 
pathway that is independent of nutrition availability, a 
potential therapeutic route that might be able to bypass 
shortcomings of calorie restriction. 
 
Fundamental biological processes are usually conserved  
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across species. Many of mechanisms regulating 
longevity are no exception, especially those involved in 
controlling cellular metabolism, nutrition sensing and 
stress response. Although the relationship of our yeast 
research to human systems is still uncertain, we are 
enthusiastic to explore this newly identified aging 
mechanism to higher organisms. Thinking ahead, one 
can imagine that by restoring the distorted homeostasis 
associated with aging one could ultimately improve the 
welfare and quality of life of aged humans.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Mixed acetylation phosphorylation cascades of intrinsic aging defense (shown in red) and DNA damage response
pathways (shown in blue). With aging, NuA4 acetylation of Sip2 declines, resulting in Snf1 activation and subsequent Sch9
phosphorylation. Forced Sip2 acetylation eliminates Snf1 activation and Sch9 phosphorylation, delays the aging process and
leads to life span extension. Similarly, following occurrence of double strand breaks (DSBs), MRN complex and CK2 are
recruited  to  the  DSB  site,  whereCK2  leads  to  the  release  of  inhibition  from  tri‐methylated  H3K9  (H3K9me3)  and  the
recruitment  of  Tip60/ATM  complex  to  MRN.  MRN  activates  Tip60  acetyltransferase activity  and  in  turn  results  in  the
acetylation and subsequent phosphorylation and activation of ATM. Ac, acetylation; Ph, phosphorylation. 
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